AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 293: H2523-H2529, 2007. First published August 3, 2007; doi:10.1152/ajpheart.00612.2007
0363-6135/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/4/H2523    most recent
00612.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morrison, R. R.
Right arrow Articles by Hofmann, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morrison, R. R.
Right arrow Articles by Hofmann, P. A.

Targeted deletion of A2A adenosine receptors attenuates the protective effects of myocardial postconditioning

R. Ray Morrison,1 Xing Lin Tan,2 Catherine Ledent,3 S. Jamal Mustafa,4 and Polly A. Hofmann2

1Division of Critical Care Medicine, St. Jude Children's Research Hospital, Memphis and 2Department of Physiology, University of Tennessee Health Sciences Center, Memphis, Tennessee; 3Universite Libre de Bruxelles, Brussels, Belgium; and 4Department of Physiology and Pharmacology, West Virginia University, Morgantown, West Virginia

Submitted 25 May 2007 ; accepted in final form 30 July 2007

Endogenous adenosine is an important ligand trigger for the cardioprotective effects of postconditioning (POC), yet it is unclear which adenosine receptor subtype is primarily responsible. To evaluate the role of A2A adenosine receptors in POC-induced protection, global ischemia-reperfusion was performed with and without POC in isolated wild-type (WT) and A2A adenosine receptor knockout (A2AKO) mouse hearts. Injury was measured in terms of postischemic functional recovery and release of cardiac troponin I (cTnI). Activation of protective signaling with POC was assessed by Akt and extracellular signal-regulated kinase (ERK) 1/2 phosphorylation. In WT hearts, POC improved recovery of postischemic developed pressure in early (81.6 ± 6.4% of preischemic baseline vs. 37.5 ± 5.6% for non-POC WT at 1 min) and late (62.2 ± 4.2% of baseline vs. 45.5 ± 5.3% for non-POC WT at 30 min) reperfusion, reduced cTnI release by 37%, and doubled the phosphorylation of both Akt and ERK1/2. These beneficial effects of POC were blocked by treatment with the selective A2A adenosine receptor antagonist ZM-241385 during reperfusion. Postischemic functional recovery, cTnI release, and phosphorylation of Akt and ERK1/2 were not different between non-POC WT and A2AKO hearts. In A2AKO hearts, POC did not improve functional recovery, reduce cTnI release, nor increase phosphorylation of Akt or ERK1/2. Thus the protective effects of POC are attenuated by both selective A2A receptor antagonism and targeted deletion of the gene encoding A2A adenosine receptors. These observations support the conclusion that endogenous activation of A2A adenosine receptors is an essential trigger leading to the protective effects of POC in isolated murine hearts.

ischemia-reperfusion; cardiac troponin I; phosphorylated Akt; phosphorylated extracellular signal-regulated kinase 1/2



Address for reprint requests and other correspondence: R. Ray Morrison, Div. of Critical Care Medicine, St. Jude Children's Research Hospital, 332 N. Lauderdale St., MS 734, Memphis, TN 38105 (e-mail: ray.morrison{at}stjude.org)




This article has been cited by other articles:


Home page
Circ. Res.Home page
A. Skyschally, P. van Caster, K. Boengler, P. Gres, J. Musiolik, D. Schilawa, R. Schulz, and G. Heusch
Ischemic Postconditioning in Pigs: No Causal Role for RISK Activation
Circ. Res., January 2, 2009; 104(1): 15 - 18.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. H. Rork, K. L. Wallace, D. P. Kennedy, M. A. Marshall, A. R. Lankford, and J. Linden
Adenosine A2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation
Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H1825 - H1833.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Xi, A. Das, Z.-Q. Zhao, V. F. Merino, M. Bader, and R. C. Kukreja
Loss of Myocardial Ischemic Postconditioning in Adenosine A1 and Bradykinin B2 Receptors Gene Knockout Mice
Circulation, September 30, 2008; 118(14_suppl_1): S32 - S37.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Murphy and C. Steenbergen
Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury
Physiol Rev, April 1, 2008; 88(2): 581 - 609.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.